Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Makes you think ;Why no big institutions on board;maybe main market:but still a penny share:Wait 12 months to "multibag" better off putting it In Stagecoach;Penny share Tip ACP
Swimming:;at least we agree on something
A lot people bought it from 12 to 9p and now see loss but this is longer than it sound. Covid play turn out not true and come back blood treatment. It got high when people hope Hemo use mice to have some speed up drug discovery treatment .in the end the CBR seem doing on cell base so nothing on mice at all . Then CBR is not on table this year yes . Only CAR T and CDX on the way out if lab to trial in whatever with ELLY . Deal or no deal will go to trial from September that will kick off hope for all of us.
Leave it on hang around and nothing can do now .
Completely agree, Pawnking.
I've generally given up on this Board but thought I would pop in.
Snaffled some more at 5.6p today. Cheap as chips. Hold for 12 months and it's a multi-bag. Just gets boring how short-termist people are. This is actually the problem for HEMO, it's low value market cap means it is PIs that are the principal investors outside of the BoD and PIs have grown to expect huge daily / weekly swings in SP over the last 12 months due to COVID volatility in SP/Markets.
Roll on ELI. I am confident the contract will come through given one would expect an RNS before now if they werent interested, plus ELI has been in discussing, testing, reviewing for over two years now. Keep the faith and top up if you can at these levels, all will be forgotten through the course of 2021.
The negotiation isn't going to be as straight forward as some suggest. Both parties will have an idea of what they believe they have contributed, remember Eli have provided Vlad and his team with a lot of resource which will impact any terms of a deal, Vlad may, or may not agree with Eli's monetary assessment of these. A continued working relationship in regards to other products need to be factored in, do either party wish to upset the other? It really would not surprise me to see a deal with a minimal, if any, amount of cash upfront but bigger rewards scheduled later. Vlad is a scientist first and foremost, and a businessmen secondarily. Being proven right and being able to help others would probably be a bigger success in his eyes, validation for years of work, with associated financial rewards being reaped later. I would love a positive update on CBR, seems any news which helps fight covid is much more important to the market.
Another super big yawn at the end of yet another week .....where is the £££££ contracts that’s what investors want to see not more land of hope and glory stuff so much hot smoke
Well, when you isolate it like that B1ll, I now see we are all actually discussing a 1970s southern rock trio from Florida. But that wasn't my intention.
"tri-state option" :-)
Yes. I do get all of that. I was merely illustrating the point that it is so easy to misunderstand what each other are saying regarding the option, because as you say, this is a tri-state option (taken up, turned down, still available) but has so far been discussed today as a binary option (either it has been taken up or it has been flat out rejected), hence the confusion.
The reason I raised the whole issue is that whether they will take it up or not is an unknown, and the unknown raises fear or apathy, and that lowers the share price. Everything since my original post on this issue so far has been everyone assuming I'm suggesting it will not be taken up.
You will see a couple of posts down that I actually say that I do think it will be taken up, for all the good reasons you state.
Stonk, until they sign on the dotted line then its still in negotiations, they have neither taken nor declined the option, but for people to sell it as Eli are not going to licence is just an argumentative de-ramping attempt. Eli Lilly are a Billion dollar company who have invested millions in CDX development and things take time. They have 3 months to take up the option, had they wanted to walk away from Hemogenyx they could have done that at any time over the last 3 years. But yet they keep signing agreements, keep funding research, but you believe what you want to believe. If you want to argue semantics on the precise words I chose then your just wasting what is very limited minutes I have during lunch.....
Stonk, how could they take them up on a product that wasn't completed?
"With regards to people saying Eli Lilly have not taken up the option. Seriously what?"
So, are you saying they HAVE actually taken up the option then?
Actively avoiding these boards these days, *(Largely because my current contract involves using a provided laptop with activity tracking software...) but Jesus on days like this I am glad!
With regards to people saying Eli Lilly have not taken up the option. Seriously what?
They have worked with Hemo on CDX for 3 years, they have agreed to extensions in that time instead of walking away.
At the end of the Development agreement Eli Lilly and Hemogenyx worked together to select the BEST antibody to licence and again that was published with the 3 month period for Eli to take up the worldwide exclusive licence. I am sorry but reading between the lines is one thing, saying Eli have spent millions on this and are one month into the 3 month period they have to licence and trying to say they have declined the licence is just pure rubbish.
Thats completely ignoring the fact that Eli this week started the manufacturing process to produce the required products for CAR-T clinical trials............... Trials that Penn have been through before with Kymriah which goes for $475k per treatment. And lets forget CBR, the proven mice worth £2k a pop and Hu-PHEC.
Anyone actually worried about the future of hemogenyx at this point has not bothered to do any research. SP is down over all because of shorting and fear mongering over CLN being used as death spiral finance which never materialised. Today looks like a mix of more shorting and MMs trying to shake some shares.
I am off back to work, but seriously, people are choosing to just listen to derampers who want you to sell to make profits on the SP falling instead of the CEO, investors who are putting their money where their mouth is, specialists and experts....
I am angry at the SP because I know that it profits people who want to do harm to the company and investors but that does not mean I am worried or concerned about it. Shorters have to close, SP will bounce, as the SP has fallen they have made money but they have also only made their exposure bigger and bigger by doubling down with the profits and shorting more shares. At some point we will have a short squeeze here and you will know it when it happens, just sit back, stew in silence if you want, but we will bounce back.